T 0142/23 of 27.03.2025
- European Case Law Identifier
- ECLI:EP:BA:2025:T014223.20250327
- Date of decision
- 27 March 2025
- Case number
- T 0142/23
- Petition for review of
- -
- Application number
- 17001347.8
- IPC class
- C07K 16/28A61K 39/39A61K 39/395
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Combination of vaccination and inhibition of the PD-1 pathway
- Applicant name
- CureVac SE
- Opponent name
- Strawman Limited
Merck Patent GmbH
BioNTech SE
eTheRNA Immunotherapies NV
Pfizer Inc.
James Poole Limited - Board
- 3.3.04
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 113(2)
- Keywords
- Basis of decision - text or agreement to text withdrawn by patent proprietor
- Catchword
- -
- Citing cases
- -
Order
For these reasons it is decided that:
The appeal proceedings are terminated.